Archive for the ‘homeslider’

Medication Overuse Headache (MOH)

17th September 2018

Medication Overuse Headache (MOH) What is it? Medication Overuse Headache (MOH) is literally what it says on the tin - a headache brought on by the overuse of acute (abortive) medication. It was originally thought to be a primary headache disorder - meaning that it was not caused by an underlying condition; however, the International Headache Society (IHS) has recently changed its status. MOH is now classed as a secondary headache, which... [read more]


Order a Pharmacy Promotional Pack

17th September 2018

Migraine Awareness Week 2018, ran from the 10th – 16th September and offered a timely opportunity to highlight the importance of community pharmacists in the effective management and support of patients with migraine and their crucial role in the timely identification and treatment of Medication Overuse Headache. The Migraine Association of Ireland with the support of Novartis has produced free information packs including posters and... [read more]


CGRP Update!! All your questions answered.

1st August 2018

CGRP Update Following member’s queries and questions around the introduction of this new drug and in response to the large volume of online comments and questions, (read our original press release here) The Migraine Association sought clarification on a number of issues with Novartis who have confirmed the following: Erenumab is the first and only treatment specifically designed for migraine prevention to be approved in the European... [read more]


Migraine Information for non-English Speakers

19th June 2018

Migraine is a disorder that affects all levels of society, gender, age, socio-economic status and nationality. Ireland has grown into a wonderfully diverse country with people from all over the world living, working, bringing their culture here, and unfortunately suffering from migraine too! It can be hard for non- English speakers to access relevant health information in Ireland and in recognition of that information gap, we have translated... [read more]


Cluster Headache: Fostering Empathy through Patients’ own Stories

20th April 2018

If you want to understand what it really means to live with cluster headache, imagine... fostering empathy through European patients’ own stories of their experiences Cluster headache (CH) is regarded as the most severe pain known to mankind. The severity of the pain has earned it the nickname “suicide headache”. Unfortunately there is a lack of empathy for people who suffer from CH and this affects how they are treated by friends,... [read more]


Archive for the ‘homeslider’

Medication Overuse Headache (MOH)

17th September 2018

Medication Overuse Headache (MOH) What is it? Medication Overuse Headache (MOH) is literally what it says on the tin - a headache brought on by the overuse of acute (abortive) medication. It was originally thought to be a primary headache disorder - meaning that it was not caused by an underlying condition; however, the International Headache Society (IHS) has recently changed its status. MOH is now classed as a secondary headache, which... [read more]


Order a Pharmacy Promotional Pack

17th September 2018

Migraine Awareness Week 2018, ran from the 10th – 16th September and offered a timely opportunity to highlight the importance of community pharmacists in the effective management and support of patients with migraine and their crucial role in the timely identification and treatment of Medication Overuse Headache. The Migraine Association of Ireland with the support of Novartis has produced free information packs including posters and... [read more]


CGRP Update!! All your questions answered.

1st August 2018

CGRP Update Following member’s queries and questions around the introduction of this new drug and in response to the large volume of online comments and questions, (read our original press release here) The Migraine Association sought clarification on a number of issues with Novartis who have confirmed the following: Erenumab is the first and only treatment specifically designed for migraine prevention to be approved in the European... [read more]


Migraine Information for non-English Speakers

19th June 2018

Migraine is a disorder that affects all levels of society, gender, age, socio-economic status and nationality. Ireland has grown into a wonderfully diverse country with people from all over the world living, working, bringing their culture here, and unfortunately suffering from migraine too! It can be hard for non- English speakers to access relevant health information in Ireland and in recognition of that information gap, we have translated... [read more]


Cluster Headache: Fostering Empathy through Patients’ own Stories

20th April 2018

If you want to understand what it really means to live with cluster headache, imagine... fostering empathy through European patients’ own stories of their experiences Cluster headache (CH) is regarded as the most severe pain known to mankind. The severity of the pain has earned it the nickname “suicide headache”. Unfortunately there is a lack of empathy for people who suffer from CH and this affects how they are treated by friends,... [read more]